- Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Department of Neurosurgery, National Hospital Organization Sendai Medical Center, Sendai, Miyagi, Japan
Correspondence Address:
Hiroyuki Sakata, Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai Miyagi, Japan.
DOI:10.25259/SNI_320_2025
Copyright: © 2025 Surgical Neurology International This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.How to cite this article: Youhei Takeuchi1,2, Hiroyuki Sakata1, Tomohisa Ishida1, Masayuki Ezura2, Hidenori Endo1. Optimal intervention for ruptured cerebral arteriovenous malformation during pregnancy. 13-Jun-2025;16:238
How to cite this URL: Youhei Takeuchi1,2, Hiroyuki Sakata1, Tomohisa Ishida1, Masayuki Ezura2, Hidenori Endo1. Optimal intervention for ruptured cerebral arteriovenous malformation during pregnancy. 13-Jun-2025;16:238. Available from: https://surgicalneurologyint.com/?post_type=surgicalint_articles&p=13630
Abstract
Background: Cerebral arteriovenous malformation (AVM) is a significant cause of hemorrhagic stroke in pregnant women. The risk of rebleeding after an initial hemorrhage during pregnancy is high, necessitating aggressive intervention and careful management. However, the optimal timing and method of intervention remain unclear. In particular, there has been little discussion regarding cases in which rebleeding occurred despite aggressive intervention. We present a case of cerebral AVM with intraventricular hemorrhage during pregnancy, which subsequently rebled after a cesarean section.
Case Description: A 30-year-old primigravida at 27 weeks of gestation presented with a sudden headache and was diagnosed with intraventricular hemorrhage. Magnetic resonance imaging revealed a flow void in the left fusiform gyrus, confirming a Spetzler–Martin Grade 2 AVM. Due to the deep location and limited safety data on Onyx use during pregnancy, surgery was postponed until after delivery. Cesarean section was planned at 32 weeks to ensure fetal viability. No rebleeding occurred preoperatively. At 32 weeks and 2 days, a cesarean section was performed under spinal anesthesia, delivering a male infant weighing 1,567 g. Postoperative computed tomography revealed intraventricular rebleeding, although no neurological deterioration occurred. Emergency transarterial embolization (TAE) with Onyx was performed the following day, followed by another TAE and AVM resection. Angiography confirmed complete lesion removal, and both the mother and child recovered favorably.
Conclusion: Considering the high rates of rebleeding and the significant maternal and fetal mortality, prioritizing rebleeding prevention may be a key component of the intervention strategy for ruptured AVMs during pregnancy.
Keywords: Arteriovenous malformation, Hemorrhagic stroke, Maternal stroke, Pregnancy
INTRODUCTION
Cerebral arteriovenous malformation (AVM), along with cerebral aneurysms, is the leading cause of hemorrhagic stroke in pregnant women.[
CASE DESCRIPTION
A 30-year-old primigravida with no significant medical history developed an intraventricular hemorrhage at 25 weeks of pregnancy following sudden headache [
Figure 1:
(a-c) Computed tomography images at 25 weeks of gestation show intraventricular hemorrhage from the left lateral ventricle to the third ventricle. (d and e) Magnetic resonance imaging taken upon transfer to our hospital at 27 weeks of gestation reveals a flow void in the fusiform gyrus of the left medial temporal lobe on T2-weighted imaging.
Figure 2:
Cerebral angiography images taken at 28 weeks of gestation. (a and b) Anteroposterior (a) and lateral views (b) in the arterial phase. The black arrow indicates the feeder, which is the posterior temporal artery. (c and d) Anteroposterior (c) and lateral views (d) in the late arterial phase. The black arrowheads indicate the drainer, which is the basal vein, and the black arrows indicate the highly narrowed straight sinus. (e and f) Anteroposterior (e) and lateral views (f) of 3D digital subtraction angiography. The white arrows indicate intranidal aneurysms.
A treatment plan involving resection was considered due to the hemorrhagic nature of AVM. Owing to its deep location, preoperative embolization with Onyx was deemed appropriate. However, concerns regarding the safety of Onyx use during pregnancy and the fact that the condition of the patient had stabilized 2 weeks after the initial hemorrhage led to a decision to delay surgery until after delivery. A cesarean section was planned at 32 weeks to ensure fetal viability, followed by transarterial embolization (TAE) and AVM resection, which were performed 4 and 5 days later, respectively.
At 32 weeks and 2 days, a cesarean section was performed under spinal anesthesia, resulting in the delivery of a 1,567 g male infant. However, during surgery, the patient developed headache, and postoperative computed tomography revealed rebleeding into the ventricles [
Figure 4:
Intraoperative findings during arteriovenous malformation resection. (a) The medial aspect was dissected along the collateral sulcus, and the lateral aspect was along the occipitotemporal sulcus. (b) Using the embolized Onyx as a marker, the extent of resection anteriorly was defined. (c) Reaching the lateral ventricle in the deep areas, the intranidal aneurysm within the lateral ventricle was confirmed. (d) As the dissection plane developed, a viable nidus was exposed. (e) The main drainer was clipped and subsequently transected. (f) The resected nidus. It is associated with an intranidal aneurysm as depicted in the digital subtraction angiography.
DISCUSSION
The optimal timing and method of intervention for hemorrhagic AVM during pregnancy are yet to be definitively established. Zhong et al. conducted a review of 112 cases of AVM hemorrhage during pregnancy, published between 1970 and 2020, and reported their findings in 2021.[
First, regarding neurosurgical interventions, past reports have suggested that surgical intervention for cerebral AVM can improve both maternal and fetal outcomes.[
Preoperative TAE is a favorable option for reducing intraoperative blood loss and minimizing surgical risks. However, potential concerns associated with the use of radiation, contrast agents, heparin, and embolic materials must be carefully considered. Rupture of AVMs during pregnancy predominantly occurs during the late gestational period, after the completion of organogenesis.[
Second, regarding obstetric interventions, there are no clear criteria regarding the delivery method before cerebral AVM resection.[
Third, regarding anesthetic interventions, there are no established guidelines regarding anesthetic methods during delivery.[
It is widely accepted that aggressive intervention should be considered for ruptured AVMs during pregnancy; however, cases of rebleeding despite such intervention have received little attention in the literature.[
CONCLUSION
We reported a case of a cerebral AVM that initially presented with intraventricular hemorrhage during pregnancy and subsequently rebled immediately after a cesarean section performed under spinal anesthesia. In cases of ruptured AVMs during pregnancy, the timing and method of intervention should be considered not only from a neurosurgical perspective but also from obstetric and anesthetic viewpoints. Considering the high rates of rebleeding and the significant maternal and fetal mortality associated with such cases, prioritizing the prevention of rebleeding may be an important aspect of the intervention strategy.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship:
Nil.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirms that there was no use of AI-assisted technology in the writing or editing of the manuscript, and no images were manipulated using AI.
Disclaimer
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Journal or its management. The information contained in this article should not be considered to be medical advice; patients should consult their own physicians for advice as to their specific medical needs.
References
1. Ahmet A, Lawson ML, Babyn P, Tricco AC. Hypothyroidism in neonates post-iodinated contrast media: A systematic review. Acta Paediatr. 2009. 98: 1568-74
2. Chen K, Lu X, Xu D, Guo Y, Ao Y, Wang H. Prenatal exposure to corn oil, CMC-Na or DMSO affects physical development and multi-organ functions in fetal mice. Reprod Toxicol. 2023. 118: 108366
3. D’Alessio JG, Ramanathan J. Effects of maternal anesthesia in the neonate. Semin Perinatol. 1998. 22: 350-62
4. De Maria L, Serioli S, Fontanella MM. Brain arteriovenous malformations and pregnancy: A systematic review of the literature. World Neurosurg. 2023. 177: 100-8
5. Dias MS. Neurovascular emergencies in pregnancy. Clin Obstetr Gynecol. 1994. 37: 337-54
6. Fukuda K, Hamano E, Nakajima N, Katsuragi S, Ikeda T, Takahashi JC. Pregnancy and delivery management in patients with cerebral arteriovenous malformation: A single-center experience. Neurol Med Chir (Tokyo). 2013. 53: 565-70
7. Garza-Mercado R, Cavazos E, Tamez-Montes D. Cerebral arteriovenous malformations in children and adolescents. Surg Neurol. 1987. 27: 131-40
8. Gross BA, Du R. Hemorrhage from arteriovenous malformations during pregnancy. Neurosurgery. 2012. 71: 349-55 discussion 355-6
9. Jermakowicz WJ, Tomycz LD, Ghiassi M, Singer RJ. Use of endovascular embolization to treat a ruptured arteriovenous malformation in a pregnant woman: A case report. J Med Case Rep. 2012. 6: 113
10. Ji Y, Liang Y, Liu B, Wang Y, Li L, Liu Y. Anaesthetic management of cerebral arteriovenous malformation hemorrhage during pregnancy: A case series. Medicine (Baltimore). 2023. 102: e32753
11. Karakida S, Sasaki T, Kai K, Harada K, Yoshimura S, Kono M. Vaginal cesarean section for second-trimester therapeutic abortion. Taiwan J Obstet Gynecol. 2013. 52: 564-7
12. King BD, Harris LC, Greifenstein FE, Elder JD, Dripps RD. Reflex circulatory responses to direct laryngoscopy and tracheal intubation performed during general anesthesia. Anesthesiology. 1951. 12: 556-66
13. Lanzino G, Jensen ME, Cappelletto B, Kassell NF. Arteriovenous malformations that rupture during pregnancy: A management dilemma. Acta Neurochir (Wien). 1994. 126: 102-6
14. Leffert LR, Schwamm LH. Neuraxial anesthesia in parturients with intracranial pathology: A comprehensive review and reassessment of risk. Anesthesiology. 2013. 119: 703-18
15. Liu XJ, Wang S, Zhao YL, Teo M, Guo P, Zhang D. Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium. Neurology. 2014. 82: 1798-803
16. Mrowczynski OD, McNutt S, Bourcier AJ, Jafrani R, Lane JR, Padmanaban V. Aneurysmal and arteriovenous malformation hemorrhage during pregnancy: An update on the epidemiology, risk factors and prognosis. Clin Neurol Neurosurg. 2021. 208: 106897
17. Ogilvy CS, Stieg PE, Awad I, Brown RD, Kondziolka D, Rosenwasser R. Recommendations for the management of intracranial arteriovenous malformations: A statement for healthcare professionals from a special writing group of the Stroke council, American stroke association. Circulation. 2001. 103: 2644-57
18. Porras JL, Yang W, Philadelphia E, Law J, Garzon-Muvdi T, Caplan JM. Hemorrhage risk of brain arteriovenous malformations during pregnancy and puerperium in a North American cohort. Stroke. 2017. 48: 1507-13
19. Robinson JL, Hall CJ, Sedzimir CB. Subarachnoid hemorrhage in pregnancy. J Neurosurg. 1972. 36: 27-33
20. Sadasivan B, Malik GM, Lee C, Ausman JI. Vascular malformations and pregnancy. Surg Neurol. 1990. 33: 305-13
21. Schirmer CM, Bulsara KR, Al-Mufti F, Haranhalli N, Thibault L, Hetts SW. Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update. J Neurointerv Surg. 2023. 15: 1155-62
22. Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke. 1995. 26: 930-6
23. Trivedi RA, Kirkpatrick PJ. Arteriovenous malformations of the cerebral circulation that rupture in pregnancy. J Obstetr Gynaecol. 2003. 23: 484-9
24. Wei HY, Lien YS, Tee YT, Shih YT, Wang PH, Chen GD. Intracerebral hemorrhage with cerebral arteriovenous malformation rupture during pregnancy. Taiwan J Obstet Gynecol. 2008. 47: 460-2
25. Wilkins RH. Natural history of intracranial vascular malformations: A review. Neurosurgery. 1985. 16: 421-30
26. Yan KL, Ko NU, Hetts SW, Weinsheimer S, Abla AA, Lawton MT. Maternal and fetal outcomes in women with brain arteriovenous malformation rupture during pregnancy. Cerebrovasc Dis. 2021. 50: 296-302
27. Yoon I, Slesinger TL, editors. Radiation exposure in pregnancy. StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. p. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532276 [Last accessed on 2025 Mar 22]
28. Zhong Z, Ni H, Zhu J, Jiang H, Hu J, Lin D. Management of acute hemorrhage caused by cerebral arteriovenous malformation during pregnancy-case series and literature review. World Neurosurg. 2021. 152: e688-99